asthma. Asthma
Conditions
Interventions
Intervention 1: In A group steroid inhaler dose will be halved and other medication will be continued. Intervention 2: In B group Montelucast will be discontinued and steroid inhaler and other medicat
Treatment - Drugs
In A group steroid inhaler dose will be halved and other medication will be continued
In B group Montelucast will be discontinued and steroid inhaler and other medication will be continued
Sponsors
Dr.Abidi Pharmaceutical Company
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion Criteria: 1: Asthmatic patients with Asthma Control Test (ACT) >20 and FEV1> 80% predicted in two sequential visits 2: Age >18 years old 3.Asthma symptoms>1 year 4: Use of asthma controller medications >3 months 5: At least 2 monthly visits by his/her physician in Imam Khomeini pulmonary clinic Exclusion Criteria: 1: Use of systemic steroids or emergency visit in the past 3 months due to asthma exacerbation 2: Pregnancy 3: Inability or unwillingness for scheduled visits by his/her physician 4: Patients request for increase in the asthma medication after enrolling in this study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Asthma control Rate. Timepoint: 3 months. Method of measurement: Asthma Control Tool and Espirometry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Exacerbation numbers. Timepoint: during study. Method of measurement: Emergency visit due to exacerbation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamidreza Abtahi
Tehran University of Medical Science
Outcome results
None listed